• Go to navigation
  • Go to content
ProstateLine

Astrazeneca Worldwide

  • AstraZeneca Websites
Astrazeneca.com

Main navigation

  • Home
  • News
  • Prostate cancer
  • AstraZeneca products
  • Treatment guidelines
  • Expert views
  • Pubmed
  • Patient support
  • Congress calendar
  • Congress reports
  • Glossary
  • Register for extra features
  • Links
  • Sitemap

HomePage

  • Prostate cancer news

    • Sep 3, 2010  : Complementary therapies ease prostate cancer patients’ anxiety

      Prostate cancer patients being treated with radiotherapy are interested in and show benefit from complementary therapies, including Reiki and relaxation response therapy, report US researchers.

    • Sep 2, 2010  : Prostate cancer mortality rates do not mirror incidence in Nordic countries

      Prostate cancer mortality rates have remained stable and even declined in Nordic countries over the past 2 decades, despite a substantial rise in the incidence of the disease, study results show.

    • Sep 2, 2010  : Percent-free PSA could reduce overdiagnosis after prostate cancer screening

      Percent-free prostate-specific antigen should be included alongside standard measures in early prostate cancer screening programs to better detect pathologically insignificant disease and thereby reduce risk for overdiagnosis, report Italian researchers.

    • Sep 1, 2010  : Physicians not confident in knowledge about prostate cancer screening

      US primary care physicians are able to correctly identify prostate cancer risk factors but are not confident in their knowledge about prostate cancer screening and overall prostate cancer risk, show study results.

    more news
Welcome to ProstateLine.com an international educational resource for healthcare professionals with an interest in prostate cancer, provided by AstraZeneca.

Not signed in

Please log in or register to access the site



  • Register
  • Forgotten password?

Information

This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below. 

  • US Patients
  • US HCPs
  • UK Patients
  • UK HCPs
  • Patients Other

Unsubscribe

Unsubscribe

Contact

Contact Us

PubMed

  • Access PubMed

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010